Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Trabikibart (Synonyms: CSL311, CSL 311)

Catalog No. T80959 Copy Product Info
Purity: 95%
🥰Excellent
Trabikibart is a fully human βc-specific monoclonal antibody, designated CSL311, that binds with picomolar affinity to the cytokine-binding epitope of the human βc receptor. Trabikibart exhibits potent inhibitory activity against the collective biological effects of IL-3, GM-CSF, and IL-5 on eosinophil survival, positioning it as a promising biologic agent for the study of chronic inflammatory and eosinophil-associated disorders.

Trabikibart

Copy Product Info
🥰Excellent
Catalog No. T80959
Synonyms CSL311, CSL 311

Trabikibart is a fully human βc-specific monoclonal antibody, designated CSL311, that binds with picomolar affinity to the cytokine-binding epitope of the human βc receptor. Trabikibart exhibits potent inhibitory activity against the collective biological effects of IL-3, GM-CSF, and IL-5 on eosinophil survival, positioning it as a promising biologic agent for the study of chronic inflammatory and eosinophil-associated disorders.

Trabikibart
Cas No. 2643974-98-3
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$123-In Stock
5 mg$297-In Stock
10 mg$463-In Stock
25 mg$747-In Stock
50 mg$987-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95.6% (SDS-PAGE); 99.3% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Trabikibart is a fully human βc-specific monoclonal antibody, designated CSL311, that binds with picomolar affinity to the cytokine-binding epitope of the human βc receptor. Trabikibart exhibits potent inhibitory activity against the collective biological effects of IL-3, GM-CSF, and IL-5 on eosinophil survival, positioning it as a promising biologic agent for the study of chronic inflammatory and eosinophil-associated disorders.
SynonymsCSL311, CSL 311
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetCSF2Rb/CD131
Chemical Properties
Molecular Weight144.64 kDa
Cas No.2643974-98-3
Antibody Information
IsotypeHuman IgG4 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Trabikibart | purchase Trabikibart | Trabikibart cost | order Trabikibart | Trabikibart molecular weight